This company is no longer active
Second Sight Medical Products Future Growth
Future criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Second Sight, Nano Precision complete merger, renaming as Vivani Medical
Aug 30Second Sight Medical sheds ~17% after reverse stock split
Aug 19Second Sight stock rises as shareholders approve merger, name change, reverse stock split
Jul 29Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial
Jul 18Revisiting Second Sight Medical Products: The EV Is Negative And Being Short No Longer Looks Appealing
Mar 22Second Sight Medical rises defying legal battle; regains NASDAQ compliance
Jun 04In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Second Sight Medical Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2022 | N/A | -9 | -9 | -9 | N/A |
3/31/2022 | N/A | -8 | -10 | -10 | N/A |
12/31/2021 | N/A | -9 | -9 | -9 | N/A |
9/30/2021 | N/A | -9 | -8 | -8 | N/A |
6/30/2021 | N/A | -8 | -8 | -8 | N/A |
3/31/2021 | N/A | -9 | -9 | -9 | N/A |
12/31/2020 | N/A | -15 | -17 | -17 | N/A |
9/30/2020 | 0 | -21 | -23 | -23 | N/A |
6/30/2020 | 1 | -27 | -28 | -28 | N/A |
3/31/2020 | 2 | -33 | -30 | -29 | N/A |
12/31/2019 | 3 | -34 | -28 | -28 | N/A |
9/30/2019 | 5 | -35 | -28 | -28 | N/A |
6/30/2019 | 6 | -36 | -29 | -29 | N/A |
3/31/2019 | 7 | -35 | -30 | -30 | N/A |
12/31/2018 | 7 | -35 | -30 | -30 | N/A |
9/30/2018 | 8 | -34 | -29 | -29 | N/A |
6/30/2018 | 8 | -32 | -26 | -26 | N/A |
3/31/2018 | 8 | -31 | -24 | -24 | N/A |
12/31/2017 | 8 | -29 | -24 | -24 | N/A |
9/30/2017 | 6 | -31 | -25 | -24 | N/A |
6/30/2017 | 5 | -33 | -26 | -26 | N/A |
3/31/2017 | 4 | -35 | -26 | -26 | N/A |
12/31/2016 | 4 | -33 | -26 | -25 | N/A |
9/30/2016 | 6 | -28 | -25 | -24 | N/A |
6/30/2016 | 7 | -24 | -24 | -23 | N/A |
3/31/2016 | 8 | -21 | N/A | -22 | N/A |
12/31/2015 | 9 | -20 | N/A | -21 | N/A |
9/30/2015 | 8 | -28 | N/A | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if EYES's forecast earnings growth is above the savings rate (1.9%).
Earnings vs Market: Insufficient data to determine if EYES's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if EYES's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if EYES's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if EYES's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EYES's Return on Equity is forecast to be high in 3 years time